antibiotics early life alter murine colonic microbiome adiposity
antibiotics administered low doses widely used growth promoters agricultural industry since 1950s yet mechanisms effect unclear antimicrobial agents different classes varying activity effective across several vertebrate species proposed subtherapeutic administration alters population structure gut microbiome well metabolic capabilities generated model adiposity giving subtherapeutic antibiotic therapy young mice evaluated changes composition capabilities gut microbiome administration subtherapeutic antibiotic therapy increased adiposity young mice increased hormone levels related metabolism observed substantial taxonomic changes microbiome changes copies key genes involved metabolism carbohydrates short-chain fatty acids increases colonic short-chain fatty acid levels alterations regulation hepatic metabolism lipids cholesterol model demonstrate alteration early-life murine metabolic homeostasis antibiotic manipulation
